“Urgent action on completing the necessary legislative processes” for the regulation of medtech products is needed in the UK, Peter Ellingworth, chief executive of the Association of British HealthTech Industries (ABHI), has said.
In a letter printed in the UK’s Financial Times on 13 October on the morning of the first in-person ABHI...






